(Q43762803)

26 November 2017

title

Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999). (English)

1 reference

26 November 2017

0 references

Buzás GM

1

1 reference

26 November 2017

Illyés G

series ordinal

2

1 reference

26 November 2017

Székely E

series ordinal

3

1 reference

26 November 2017

Széles I

series ordinal

4

1 reference

26 November 2017

publication date

1 January 2001

1 reference

Journal of Physiology (Paris)

26 November 2017

published in

1 reference

26 November 2017

volume

95

1 reference

26 November 2017

issue

1-6

1 reference

26 November 2017

page(s)

437-441

1 reference

Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Resistance of Helicobacter pylori to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

The report of the Digestive Health InitiativeSM International Update Conference on Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-4257%2801%2900060-2

7 January 2021

10.1016/S0928-4257(01)00060-2

Identifiers

DOI

1 reference

26 November 2017

1 reference